Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.
Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page
- Check3 days agoChange DetectedThe website has added multiple new contacts for medical professionals and updated the version from v2.13.3 to v2.14.0, while removing a few contacts and the previous type of intervention.SummaryDifference5%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference3%
- Check53 days agoChange DetectedThe website has added new features for user interaction, while several links and detailed data fields related to clinical studies have been removed.SummaryDifference4%
- Check60 days agoChange DetectedThe website has been updated to version v2.12.2, adding new resources and data fields for clinical studies, while the previous version v2.12.1 has been removed.SummaryDifference5%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.